Envista Holdings Corporation reports recurring developments as a global dental products company serving dental professionals through consumables, technologies, equipment and services. Its public updates center on quarterly results, core sales trends, adjusted earnings measures, cash flow, share repurchase activity and management presentations at healthcare conferences.
Company news also covers product and brand activity across DEXIS, Kerr, Nobel Biocare and Ormco, including dental implants, orthodontics, digital imaging, restorative and endodontic solutions. Recent product announcements include Kerr Dental's ZenSeal Pro with ZenSave Tips, reflecting Envista's focus on dental workflow, treatment technology and clinician-facing product commercialization.
Envista Holdings (NYSE: NVST) will announce its second quarter 2024 financial results on Wednesday, August 7, 2024. The company has scheduled a conference call for the same day at 2:00 PM PT to discuss these results. The call will include a slide presentation and will be available via webcast on the 'Investors' section of Envista's website. A replay of the webcast will be accessible shortly after the call and will be available for one year. To join the call, dial 800-579-2543 (U.S.) or +1 785-424-1789 (international) and refer to conference ID #9467851. Presentation materials will be available on the company's website before the call.
Envista Holdings (NYSE: NVST) and its charitable branch, the Envista Smile Project, announced a $2.1 million donation to the University of Southern California's (USC) Herman Ostrow School of Dentistry.
This donation aims to support the Dental Health Equity and Access to Care Initiative, focusing on underserved communities, particularly children with special needs in California. The three-year donation will provide essential oral health equipment, products, and technology updates. It will also expand the USC Pediatric Clinic and Mobile Clinic, enhancing services for special needs patients, telehealth, and general care for vulnerable populations.
This partnership includes other philanthropic endeavors, like medical mission trips staffed by USC students and faculty, to bring oral care to international communities in need.
Envista Holdings (NYSE: NVST) announced its participation in the Stifel Jaws & Paws Conference, scheduled for May 29, 2024. The event will include a Fireside Chat from 4:10 to 4:40 pm ET. An audio-only recording of the session will be available on the company's Investor Relations website for up to 365 days after the event.
Envista Holdings (NYSE: NVST) reported sales of $623.6 million for the first quarter of 2024, with a 0.4% increase in core sales compared to 2023. Net income was $23.6 million, adjusted net income $45.8 million, and adjusted EBITDA $87.2 million. The company appointed Paul Keel as the new CEO. Envista remains focused on growth and profitability with a strong outlook for the future.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.